Pharmaceutical Executive
December 19, 2014
Column
12
How pharma companies can catch up to the requirements of the modern marketing model.
December 19, 2014
Column
12
New ways for pharma to make sure its sales reps stay sharp amid a flood of new information and a more complex selling climate.
December 16, 2014
From the Editor
12
THE CALENDAR SAYS IT'S WRAP UP TIME, not just for gifts, but for some of the trends that shaped big Pharma-for good or bad-during the past year. A simple way to close the book on 2014 is to draw some insights from our three feature stories this month.
December 15, 2014
Column
12
Foreign governments are enacting anti-fraud legislation as part of broader efforts to crack down on corrupt practices involving pharmaceutical companies and healthcare professionals.
December 14, 2014
Features
12
Two words define the future of commercialization project management: Faster and Better
December 12, 2014
Column
12
Building an effective drug forecasting model today requires a revamped approach.
December 10, 2014
Features
12
partnerships, big pharma, data exchange, Business Development, M&A, Business Strategy, information exchange, dealmaking, Rebecca Ashkenazy, Alex Chang, Cyndi Green, Ted Miller, Christine de los Reyes, targeted medicine, R&D productivity
December 01, 2014
Special Sponsored Section
12
Once considered a healthcare backwater, Algeria's expanding pharmaceuticals market is taking the African continent by storm.